Willem A Robberts

Will is the President and Chief Financial Officer of LIPAC Oncology and TesoRx Pharma. Will has more than 20 years of experience in finance and operational excellence in healthcare, software and technology companies.

Prior to founding TesoRx Pharma he held executive leadership positions at a variety of companies, growing the businesses and successfully executing mergers and acquisitions. Most recently he managed more than 50 offices and more than 1,000 employees at Esquire Deposition Solutions, where he worked on the restructuring and ultimate sale of the company to Bayside Capital. Prior to that, Will served as President of LiveNote, where he grew the business to become the market leader in litigation software and sold it to Thomson Reuters. He also successfully sold AccountMate Software to Sage Accounting.

Will started his career with KPMG in South Africa where he was first involved in international business working on landmark transactions in a variety of sectors. Will attended the University of Johannesburg where he earned degrees in Business Communications, Accounting and Management. Will serves on the Board of several pharmaceutical and technology companies and is passionate about providing solutions for patients living with unmet needs.